CVE-2026-7398 — Katalog CVE

csirt@kutim:~/threat-intel/cve/CVE-2026-7398

CVSS 7.3 · High EPSS 0,59%

Kerentanan Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'). Skor CVSS 3.1 7.3 (High) menurut vuldb.com.

Deskripsi (NVD)

A weakness has been identified in florensiawidjaja BioinfoMCP up to 7ada7918b9e515604d3c0ae264d3a9af10bf6e54. This vulnerability affects the function Upload of the file bioinfo_mcp_platform/app.py of the component Upload Endpoint. This manipulation of the argument Name causes path traversal. The attack can be initiated remotely. The exploit has been made available to the public and could be used for attacks. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. The project was informed of the problem early through an issue report but has not responded yet.

Rincian

Terbit di NVD: 29 April 2026
Terakhir diubah: 17 Juni 2026
Status NVD: Deferred
CVSS 3.1: 7.3 (High), sumber vuldb.com
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L · uraikan di kalkulator
Jenis kelemahan (CWE): CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
EPSS (30 hari): 0,59% peluang dieksploitasi; lebih tinggi dari 46,5% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.